( ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the European Medicines ...
https://www.google.com/url?rct=j&sa=t&url=https://www.gurufocus.com/news/1800437/adverum-biotechnologies-granted-priority-medicines-prime-designation-by-european-medicines-agency-for-advm022-in-wet-amd&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw2jE3QMsw_627LHArTVL4im
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.